Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3863 | 1819 | 28.3 | 49% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARBAMAZEPINE 10 11 EPOXIDE | Author keyword | 28 | 57% | 2% | 34 |
2 | FREE PHENYTOIN | Author keyword | 19 | 80% | 1% | 12 |
3 | R 4PK | Address | 6 | 100% | 0% | 4 |
4 | R4PK | Address | 5 | 47% | 0% | 8 |
5 | CARBAMAZEPINE 10 11 EPOXIDE | Author keyword | 5 | 63% | 0% | 5 |
6 | CARBAMAZEPINE DIOL | Author keyword | 4 | 75% | 0% | 3 |
7 | FREE LEVELS | Author keyword | 4 | 75% | 0% | 3 |
8 | CARBAMAZEPINE EPOXIDE | Author keyword | 3 | 43% | 0% | 6 |
9 | CARBAMAZEPINE 10 11 DIOL | Author keyword | 3 | 100% | 0% | 3 |
10 | FREE DIGITOXIN | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARBAMAZEPINE 10 11 EPOXIDE | 28 | 57% | 2% | 34 | Search CARBAMAZEPINE+10+11+EPOXIDE | Search CARBAMAZEPINE+10+11+EPOXIDE |
2 | FREE PHENYTOIN | 19 | 80% | 1% | 12 | Search FREE+PHENYTOIN | Search FREE+PHENYTOIN |
3 | CARBAMAZEPINE 10 11 EPOXIDE | 5 | 63% | 0% | 5 | Search CARBAMAZEPINE+10++11+EPOXIDE | Search CARBAMAZEPINE+10++11+EPOXIDE |
4 | CARBAMAZEPINE DIOL | 4 | 75% | 0% | 3 | Search CARBAMAZEPINE+DIOL | Search CARBAMAZEPINE+DIOL |
5 | FREE LEVELS | 4 | 75% | 0% | 3 | Search FREE+LEVELS | Search FREE+LEVELS |
6 | CARBAMAZEPINE EPOXIDE | 3 | 43% | 0% | 6 | Search CARBAMAZEPINE+EPOXIDE | Search CARBAMAZEPINE+EPOXIDE |
7 | CARBAMAZEPINE 10 11 DIOL | 3 | 100% | 0% | 3 | Search CARBAMAZEPINE+10+11+DIOL | Search CARBAMAZEPINE+10+11+DIOL |
8 | FREE DIGITOXIN | 3 | 100% | 0% | 3 | Search FREE+DIGITOXIN | Search FREE+DIGITOXIN |
9 | FREE VALPROIC ACID | 3 | 100% | 0% | 3 | Search FREE+VALPROIC+ACID | Search FREE+VALPROIC+ACID |
10 | ALTERATION RATIO | 3 | 60% | 0% | 3 | Search ALTERATION+RATIO | Search ALTERATION+RATIO |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARBAMAZEPINE 10 11 EPOXIDE | 83 | 66% | 4% | 78 |
2 | UNBOUND PHENYTOIN | 27 | 92% | 1% | 11 |
3 | PRINCIPAL METABOLITES | 22 | 81% | 1% | 13 |
4 | PHENYTOIN CONCENTRATIONS | 19 | 70% | 1% | 16 |
5 | MICHAELIS MENTEN PHARMACOKINETICS | 18 | 89% | 0% | 8 |
6 | ANALYSIS COMPUTER PROGRAM | 15 | 88% | 0% | 7 |
7 | BAYESIAN REGRESSION ANALYSIS | 15 | 88% | 0% | 7 |
8 | LEVEL DOSE RATIOS | 12 | 86% | 0% | 6 |
9 | ACID RELATIVE CLEARANCE | 11 | 100% | 0% | 6 |
10 | EPILEPTIC PATIENTS | 10 | 12% | 4% | 76 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva | 2013 | 20 | 184 | 39% |
Extended-release formulations for the treatment of epilepsy | 2007 | 23 | 43 | 70% |
Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management | 2007 | 42 | 105 | 42% |
Therapeutic drug concentration monitoring using saliva samples - Focus on anticonvulsants | 1999 | 62 | 85 | 62% |
CLINICAL PHARMACOKINETICS OF ANTIEPILEPTIC DRUGS IN PEDIATRIC-PATIENTS .2. PHENYTOIN, CARBAMAZEPINE, SULTHIAME, LAMOTRIGINE, VIGABATRIN, OXCARBAZEPINE AND FELBAMATE | 1995 | 52 | 87 | 76% |
Clinically significant pharmacokinetic drug interactions with carbamazepine - An update | 1996 | 201 | 132 | 40% |
A mechanistic approach to antiepileptic drug interactions | 1998 | 144 | 53 | 38% |
Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies | 2008 | 185 | 345 | 24% |
Extended-release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate-release formulations | 2013 | 10 | 34 | 35% |
CLINICAL PHARMACOKINETICS OF ANTIEPILEPTIC DRUGS IN PEDIATRIC-PATIENTS .1. PHENOBARBITAL, PRIMIDONE, VALPROIC ACID, ETHOSUXIMIDE AND MESUXIMIDE | 1995 | 52 | 78 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | R 4PK | 6 | 100% | 0.2% | 4 |
2 | R4PK | 5 | 47% | 0.4% | 8 |
3 | HORMONOL THER EUT DRUG MONITORING | 2 | 67% | 0.1% | 2 |
4 | STUDIES DRUG DISPOSIT | 2 | 26% | 0.3% | 6 |
5 | EBN SINA HOSP | 1 | 100% | 0.1% | 2 |
6 | MEM HERMANN | 1 | 50% | 0.1% | 2 |
7 | ORPHAN DRUG | 1 | 15% | 0.3% | 5 |
8 | CLIN CLIN PHARMACOL SHINJUKU KU | 1 | 50% | 0.1% | 1 |
9 | DENT HOSP PHARM OHTA KU | 1 | 50% | 0.1% | 1 |
10 | HLTH SCI PHARMACEUT SCI | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000226550 | PHARMACEUT DEV DEV//QUALITY OF HEALTH CARE SERVICES//TEST PERFORMANCE CHARACTERISTICS |
2 | 0.0000197885 | GENIUS R//CHARCOAL HEMOPERFUSION//CARBAMAZEPINE INTOXICATION |
3 | 0.0000169078 | LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE |
4 | 0.0000151061 | VALPROIC ACID//VALPROATE//TRANS 2 EN VALPROATE |
5 | 0.0000132120 | PHARMACOL RE6640//SPP301//AVOSENTAN |
6 | 0.0000120835 | FLUORESCENT FOCUS ASSAY//FUYOU BRANCH//GLOBAL NEUROL PROGRAM |
8 | 0.0000086981 | BOUCICAUT//COVERT MEDICATION//CRUSHED DRUGS |
9 | 0.0000085042 | AUDITORY DISTURBANCE//PERIPHERAL NEUROMUSCULAR FUNCTION//ACUTE FORM |
10 | 0.0000080220 | APOENZYME REACTIVATION IMMUNOASSAY//BIOCHEM 555 UNIV AVE//CHEM 1 |